Skip to main content
TipRanks
Go Ultimate75% OFF

Apex Biotechnology Corp. (1733) Balance Sheet

Apex Biotechnology Corp. Balance Sheet

Apex Biotechnology Corp.'s total assets for Q2 2026 were NT$2.55B, an increase of 2.47% from the previous quarter. TW:1733 total liabilities were NT$690.93M for the fiscal quarter, a 3.67% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 2.42BNT$ 2.42BNT$ 2.30BNT$ 2.51BNT$ 2.67B
NT$ 545.32MNT$ 595.70MNT$ 500.07MNT$ 696.81MNT$ 916.91M
NT$ 1.87BNT$ 1.82BNT$ 1.80BNT$ 1.82BNT$ 1.75B

Currency in TWD

Apex Biotechnology Corp. Liabilities to Assets

01B2B3B20 %30 %40 %50 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets